Exchange: NASDAQ·Updated 05:01 PM EDT
AIMD logo

AIMD Ainos Inc

$1.60
$0.04
(2.56%)
Today
Closed $1.60
$0.02
(1.25%)
After Hours
Mkt Cap$11.81M
Vol46,677.00

About AIMD

Ainos, Inc. (NASDAQ: AIMD) is a dual-platform AI and biotechnology company based in San Diego, California, pioneering the digitization of scent with its proprietary AI Nose platform and advancing immune therapeutics. Their AI Nose technology, powered by a breakthrough smell language model, enables machine olfaction for applications in industries such as semiconductor manufacturing, robotics, smart factories, senior care, and women’s health. The company is also developing VELDONA, a low-dose oral interferon alpha with clinical programs targeting rare, autoimmune, and infectious diseases for both humans and animals. With recent industrial deployments and recurring revenue contracts in Asia, Ainos aims to transform diagnostics, preventive medicine, and industrial monitoring through innovative SmellTech and biotech solutions.
63

Bullish Sentiment

How do you feel about AIMD?

Advertisement|Remove ads.